Retention in HIV Care for Hispanic Immigrants
ADELANTE
Addressing Barriers to Retention in HIV Care for Hispanic Immigrants
2 other identifiers
interventional
67
1 country
1
Brief Summary
A randomized trial to test the feasibility and acceptability of an intervention to improve retention in HIV primary care in HIV-infected Hispanic immigrants compared to a "treatment as usual" condition. We will measure feasibility, acceptability, study retention, and effect sizes of outcomes in order to inform a larger trial. The intervention design is based on qualitative research with HIV-infected Hispanic immigrants and their HIV providers. The intervention will be led by a Spanish-speaking community health worker trained in HIV health promotion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 26, 2017
CompletedFirst Submitted
Initial submission to the registry
March 7, 2018
CompletedFirst Posted
Study publicly available on registry
March 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedResults Posted
Study results publicly available
December 23, 2022
CompletedDecember 23, 2022
December 1, 2022
1.9 years
March 7, 2018
July 27, 2022
December 1, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Retention in Care - Yes Responses
A dichotomized outcome (yes/no) with yes defined as at least one visit to HIV clinic at both time periods (week 1-16 and week 17-32), and no defined as no HIV visit from at least one time period. Responses determined by review of the medical record for evidence of attended HIV clinic visits.
32 weeks
Secondary Outcomes (4)
Number of Participants With HIV Viral Load Suppression up to Week-24
From baseline to week-24
Change in CD4 T-cell Count Over 24 Weeks
From baseline to week-24
Number of Participants With HIV Viral Load Suppression up to 48 Weeks.
Baseline to week-48
Change in CD4 T-cell Count Over 48 Weeks.
Baseline to week-48
Study Arms (2)
Treatment as Usual
NO INTERVENTIONParticipants in this arm will receive bilingual written materials on healthy living with HIV at the baseline visit. At baseline and exit, all participants will be assessed using instruments to measure demographics and self-perceived barriers to care for Hispanic immigrants.
Community Health Worker
EXPERIMENTALParticipants in the intervention arm will receive 5 one-on-one sessions over 24 weeks with a Spanish-speaking CHW. At baseline and exit, all participants will be assessed using instruments to measure demographics and self-perceived barriers to care for Hispanic immigrants
Interventions
Participants will receive 5 one-on-one sessions with a CHW over 24 weeks.
Eligibility Criteria
You may qualify if:
- Age 18 years or older and able to communicate in Spanish or English
- Born in Puerto Rico or Spanish-speaking Latin American country
- HIV-infected or HIV-positive
- New HIV diagnosis or unable to regularly attend HIV primary care appointments
You may not qualify if:
- Unable to provide verbal consent due to unstable medical or psychiatric condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Julie Levison, PI
- Organization
- Massachusetts General Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Julie H Levison, MD
Massachusetts General Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, MPhil, MPH, Assistant Professor of Medicine at Harvard Medical School
Study Record Dates
First Submitted
March 7, 2018
First Posted
March 30, 2018
Study Start
May 26, 2017
Primary Completion
May 1, 2019
Study Completion
May 1, 2019
Last Updated
December 23, 2022
Results First Posted
December 23, 2022
Record last verified: 2022-12